APA (7th ed.) Citation

A, V., M, P., OG, C., L, V., JC, J., A, G., . . . D, G. (2016). More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura. Hematology (Amsterdam, Netherlands), 21(5), 311. https://doi.org/10.1080/10245332.2015.1133008

Chicago Style (17th ed.) Citation

A, Vazquez-Mellado, et al. "More About Low-dose Rituximab and Plasma Exchange as Front-line Therapy for Patients with Thrombotic Thrombocytopenic Purpura." Hematology (Amsterdam, Netherlands) 21, no. 5 (2016): 311. https://doi.org/10.1080/10245332.2015.1133008.

MLA (9th ed.) Citation

A, Vazquez-Mellado, et al. "More About Low-dose Rituximab and Plasma Exchange as Front-line Therapy for Patients with Thrombotic Thrombocytopenic Purpura." Hematology (Amsterdam, Netherlands), vol. 21, no. 5, 2016, p. 311, https://doi.org/10.1080/10245332.2015.1133008.